These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32707053)

  • 21. Morphoproteomic and pharmacoproteomic rationale for mTOR effectors as therapeutic targets in head and neck squamous cell carcinoma.
    Brown RE; Zhang PL; Lun M; Zhu S; Pellitteri PK; Riefkohl W; Law A; Wood GC; Kennedy TL
    Ann Clin Lab Sci; 2006; 36(3):273-82. PubMed ID: 16951268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proteomics approach to identifying novel protein targets involved in erinacine A-mediated inhibition of colorectal cancer cells' aggressiveness.
    Lee KC; Kuo HC; Shen CH; Lu CC; Huang WS; Hsieh MC; Huang CY; Kuo YH; Hsieh YY; Teng CC; Lee LY; Tung SY
    J Cell Mol Med; 2017 Mar; 21(3):588-599. PubMed ID: 27709782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
    D'Angelo L; Piazzi G; Pacilli A; Prossomariti A; Fazio C; Montanaro L; Graziani G; Fogliano V; Munarini A; Bianchi F; Belluzzi A; Bazzoli F; Ricciardiello L
    Carcinogenesis; 2014 Oct; 35(10):2314-20. PubMed ID: 25123131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.
    Alabdullah ML; Ahmad DA; Moseley P; Madhusudan S; Chan S; Rakha E
    J Obstet Gynaecol; 2019 May; 39(4):522-528. PubMed ID: 30712414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma.
    Kim SH; Chau GC; Jang YH; Lee SI; Pyo S; Um SH
    Hum Pathol; 2013 Feb; 44(2):226-36. PubMed ID: 22944293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR/S6K1 signaling mediated partly by SIRT1 downregulation.
    Cao M; Zhang Z; Han S; Lu X
    Mol Med Rep; 2019 May; 19(5):3941-3947. PubMed ID: 30864709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis.
    Zhou Q; Deng Z; Zhu Y; Long H; Zhang S; Zhao J
    Med Oncol; 2010 Dec; 27(4):1239-45. PubMed ID: 19936974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Critical Role of Rab31 in Cell Proliferation and Apoptosis in Cancer Progression.
    Pan Y; Zhang Y; Chen L; Liu Y; Feng Y; Yan J
    Mol Neurobiol; 2016 Sep; 53(7):4431-7. PubMed ID: 26245486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
    Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
    Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luteoloside induces G
    Zhou M; Shen S; Zhao X; Gong X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
    Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
    Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the AKT/mTOR/S6K signalling pathway.
    Li N; Wang Y; Liu L; Wang P; Wu X
    J Obstet Gynaecol; 2023 Dec; 43(1):2151354. PubMed ID: 36484512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated mTOR/P70S6K signaling pathway is involved in insulinoma tumorigenesis.
    Zhan HX; Cong L; Zhao YP; Zhang TP; Chen G; Zhou L; Guo JC
    J Surg Oncol; 2012 Dec; 106(8):972-80. PubMed ID: 22711648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 36. GNG7 silencing promotes the proliferation and differentiation of placental cytotrophoblasts in preeclampsia rats through activation of the mTOR signaling pathway.
    Lai WS; Ding YL
    Int J Mol Med; 2019 May; 43(5):1939-1950. PubMed ID: 30864685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of Panax notoginseng saponins on proliferation, apoptosis and cell cycle of K562 cells in vitro and the mechanisms].
    Li Y; Zhai W; Yang X; Ding J; Kan L
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(8):1103-9. PubMed ID: 26277504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.